找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Core Concepts in Hypertension in Kidney Disease; Ajay K. Singh,Rajiv Agarwal Book 2016 Springer Science+Business Media, LLC, part of Sprin

[復(fù)制鏈接]
樓主: digestive-tract
11#
發(fā)表于 2025-3-23 13:08:52 | 只看該作者
Assessment of Hypertension in Chronic Kidney Disease,e, thus representing the preferred method for the diagnosis of hypertension. Although clinical trial evidence to support the use of home and ambulatory BP to guide treatment among patients with chronic kidney disease is sparse, observational data suggest that these techniques add value to the management of hypertensive patients.
12#
發(fā)表于 2025-3-23 17:30:37 | 只看該作者
13#
發(fā)表于 2025-3-23 20:25:33 | 只看該作者
ugh lifestyle changes. ?Specialist patient populations and hypertension and causes of hypertension are also covered in detail. ?Clinically-focused and authoritative, this resource offers a rationalized approach to diagnosing and treating hypertension in CKD..978-1-4939-8199-1978-1-4939-6436-9
14#
發(fā)表于 2025-3-23 22:37:08 | 只看該作者
15#
發(fā)表于 2025-3-24 03:01:13 | 只看該作者
16#
發(fā)表于 2025-3-24 09:51:21 | 只看該作者
David S. Rosenblatt,Jennifer Fitzpatrick evolves as does secondary hypertension. Multiple pathologies can cause renal artery stenosis, mostly commonly atherosclerotic renovascular disease (ARVD), followed by fibromuscular disease (FMD). It is important to differentiate between the various types of renovascular disease, since each has its
17#
發(fā)表于 2025-3-24 11:15:10 | 只看該作者
Spiritual Dimensions of Whole Person Care,uggesting that resistant hypertension is strongly associated with elevated risks for adverse cardiovascular outcomes and progression to end-stage-renal-disease both in the general hypertensive population and in CKD. Before making the diagnosis of resistant hypertension, common factors related to pse
18#
發(fā)表于 2025-3-24 18:33:03 | 只看該作者
Prevention and Whole Person Care,ociated with improved eGFR. ACE inhibitors and angiotensin receptor blockers are not recommended in the first 3-6 months given their effects on reduced eGFR, anemia and hyperkalemia. The use of ?blockers may be associated with improved patient survival, even for patients with no history of cardiovas
19#
發(fā)表于 2025-3-24 22:18:31 | 只看該作者
20#
發(fā)表于 2025-3-24 23:55:39 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 20:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
申扎县| 隆子县| 遵义市| 迁西县| 南漳县| 吴忠市| 通河县| 泰顺县| 平山县| 裕民县| 通江县| 吉安市| 梅河口市| 房山区| 巫山县| 房山区| 博爱县| 乐山市| 昔阳县| 永州市| 巧家县| 太谷县| 将乐县| 甘泉县| 辽源市| 资溪县| 宁强县| 合作市| 霸州市| 富裕县| 梅河口市| 曲阜市| 尼勒克县| 南乐县| 星子县| 吴旗县| 会理县| 涪陵区| 郸城县| 扬州市| 灌南县|